(4-Bromo-1H-imidazol-2-yl)methanol

Catalog No.: 
ACBUEW068
CAS No.: 
1804129-02-9
Molecular Formula: 
C4H5BrN2O
Molecular Weight: 
177.00
(4-Bromo-1H-imidazol-2-yl)methanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$190.00InquiryInquiry
100mg95%$277.00In stockInquiry
250mg95%$442.00In stockInquiry
500mg95%$734.00In stockInquiry
1g95%$1099.00In stockInquiry
5g95%$3297.00In stockInquiry
10g95%$5494.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-Bromo-1H-imidazol-2-yl)methanol
IUPAC Name(4-bromo-1H-imidazol-2-yl)methanol
MDL No.MFCD27922792
Molecular FormulaC4H5BrN2O
Molecular Weight177.00
SMILESOCC1=NC(Br)=CN1
InChI KeyABAMLDFAOYYEGL-UHFFFAOYSA-N
Synonym(4-Bromo-1H-imidazol-2-yl)methanol;(5-bromo-1H-imidazol-2-yl)methanol;1H-Imidazole-2-methanol, 5-bromo-;4-Bromo-2-(hydroxymethyl)-1H-imidazole
CAS No.1804129-02-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBUEW068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXEGA706 route compound structure diagram
    ACXEGA7061622843-37-1In Stock
  2. Then
  3. ACBUEW068 route product structure diagram
    ACBUEW0681804129-02-9In Stock
Inquiry

2. ACBUEW068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSCXW428 route compound structure diagram
    ACSCXW4281260876-31-0In Stock
  2. Then
  3. ACBUEW068 route product structure diagram
    ACBUEW0681804129-02-9In Stock
Inquiry

3. ACBUEW068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTYXI743 route compound structure diagram
    ACTYXI743944900-49-6In Stock
  2. Then
  3. ACBUEW068 route product structure diagram
    ACBUEW0681804129-02-9In Stock
Inquiry

Comments (0)